EUVIMEDEUVIMED entdecken
Crossref

Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis

Maarten Postma, Robert Welte, Anneke van den Hoek, Gerard van Doornum, Dieke Mulder-Folkerts, Roel Coutinho, Hans Jager

HEPAC Health Economics in Prevention and Care · 2000

DOI: 10.1007/s101980070003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HEPAC Health Economics in Prevention and Care, 2000. Verfasst von Maarten Postma und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Postma, M., Welte, R., Hoek, A. V. D., Doornum, G. V., Mulder-Folkerts, D., Coutinho, R., & Jager, H. (2000). Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis. HEPAC Health Economics in Prevention and Care. https://doi.org/10.1007/s101980070003

Vancouver

Postma M, Welte R, Hoek AVD, Doornum GV, Mulder-Folkerts D, Coutinho R, et al. Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis. HEPAC Health Economics in Prevention and Care. 2000. doi:10.1007/s101980070003

BibTeX
@article{Postma2000,
  author = {Postma, Maarten and Welte, Robert and Hoek, Anneke van den and Doornum, Gerard van and Mulder-Folkerts, Dieke and Coutinho, Roel and Jager, Hans},
  title = {Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis},
  journal = {HEPAC Health Economics in Prevention and Care},
  year = {2000},
  doi = {10.1007/s101980070003}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche